SEC Form 4 · accession 0001651844-17-000008
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jul 28, 2017
Accepted (ET)
Aug 1, 2017 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2017 | P | 5,000 | $3.77 | A | 3,062,550 | D | |
| Common Stock | Jul 31, 2017 | P | 5,000 | $3.72 | A | 3,067,550 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $3.67 | A | 3,072,550 | D | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.